In March 1969, an outbreak of upper respiratory illness occurred among new recruits at the San Clemente Sasebas military camp in Gerona, Spain. Among a randomly selected group of cases studied in detail, influenza A and adenovirus (AV) types 3, 7a, and 11 were involved to varying extents; however, AV 11 was the predominant etiologic agent (9) . Initial antigenic characterization of the influenza A and AV 3 and 7a isolates was unremarkable in that these were typical or currently endemic strains. In contrast, the AV 11 isolates were uniformly atypical, because they lacked readily detectable hemagglutinins and were identifiable only by neutralization tests (9) . An extensive study of these atypical AV 11 isolates was then initiated to determine whether they were intermediate strains and whether the presence of multiple viruses in the upper respiratory illness outbreak somehow effected the origin of these strains.
MATERIALS ANI) METHODS Strain purification. Virus strains 266 and 273 were originally recovered in human epidermoid carcinoma (HEp-2) cell cultures (9) . The strains were passaged thenceforth only in HEp-2 and primary human embryonic kidney (HEK) cells. Both viruses were strain purified by consecutive triple terminal 354 dilution passages in HEK, followed by triple end point dilution plaque purifications in HEp-2, as previously described (5) .
Sterility checks on stock passages were performed by inoculating bacteriological, mycological, and mycoplasmal media to reveal nonviral contaminants (8) , by breakthrough neutralization tests to detect other complete viruses (3, 6) , and by complement fixation (CF) tests (1, 12) and electron microscopy to reveal AV-associated virus types 1 to 4 (5, 12, 14) . Antisera to the strain-purified viruses were prepared in New Zealand white rabbits and Hartley strain guinea pigs by three biweekly subcutaneous injections of virus in Freund incomplete adjuvant, with exsanguination 2 weeks after the last injection (6) .
Virus characterization. Classical virus characterization procedures were used to place the strains in the proper group (13, 15, 22) . Nucleic acid type, acridine orange staining, chloroform and acid stability, and temperature stability with or without 1 M MgCl2 were determined as described (5) . Electron microscopy was carried out by pseudoreplica examination of concentrated supernatant fluids from infected HEK cells (5 (20) .
RESULTS
The epidemiology of the upper respiratory illness outbreak, during which these atypical strains were isolated, has been described in an earlier report (9) . For 13 of the 25 cases studied in detail, the etiologic agent was AV "11" alone (nine cases) or AV "11" followed by influenza A [A/Hong Kong/8/68(H3N2)], which was endemic in Spain and most of Europe in 1969 (17, 18) . The clinical features, sources of virus isolation, and serological confirmation of infection in these cases are presented in Table 1 . AV "11" was isolated in HEp-2 cell cultures from throat swabs from six of eight patients (75%) between 2 and 5 days after onset of clinical illness. The virus was also recovered from the rectal swab taken 6 days after onset from one of these six patients. The same strain apparently infected the two patients with negative cultures and five from whom no cultures were obtained, because HI and SN tests with selected AV "11" isolates and with acute and convalescent sera from all 13 patients revealed serological responses consistently similar within the entire group.
On initial testing, the AV "11" isolates replicated to high infectivity titers in tissue Supernatant fluids from virus-infected cells, harvested 2 days after complete cytopathology, contained soluble CF and HA antigens characteristic of the AV group. In CF block titrations these cultures had antigen titers of 1:16 against 1:256 titers (optimal dilutions) of AV 2 hexon mouse immune ascitic fluid, but no titer with antisera to herpes simplex or respiratory syncytial viruses. HA tests with erythrocytes from human 0 cells, rats, mice, gerbils, guinea pigs, dogs, chickens, geese, turkeys, cows, and sheep were consistently negative at 37 and 2 C (4). HA tests with erythrocytes from 44 different rhesus and vervet monkeys were essentially negative, with erythrocytes from only two rhesus monkeys giving HA titers at 37 C as high as 1:4 or 1:8. The erythrocytes from these same two monkeys were agglutinated with prototype AV 11 to 1:8,192 titers and with prototype AV 14 to 1:512 titers, indicating that these were exceptionally sensitive erythrocytes.
Antigenic characterization of the strain-purified isolates was carried out by complete reciprocal HI and SN testing. Rabbit and guinea pig antisera to the isolates were used with reference equine antisera to AV 1 to 33 (7) and rabbit antisera to candidate AV types 34 (5) and 35 (16) to determine interrelationships among prototype AV 1 to 35 strains and the AV "11" strains. The results are shown in Table 2 . The virus strains are clearly identifiable with prototype AV 11 antisera by SN'tests but not by HI tests. Reciprocally, the strain-specific antisera suggest that the strains are AV 14 by HI tests and AV 11 by SN tests. Only rabbit antisera data are shown in Table 2 , but guinea pig antisera, prepared with the same immunizing antigens, had HI and SN titers identical to those for the rabbit sera. We therefore classify these AV "11" isolates as AV Acute (S-1), convalescent (S-2), and late convalescent (S-3) sera from all 13 AV "11" patients were tested by HI and SN against the prototype strains of AV 3, 7a, 11, 14, 16 and 21 and against representative strains of AV 3, 7a, and 14-11 isolated during this outbreak. The data on the six patients with positive AV 14-11 isolations are representative of the 13 and are shown in Table 3 . The CF antibody response to the group-specific hexon antigen observed in all patients was typical of AV infections. Prior experience with AV 3 and 7a was evident in seven patients (five shown in Table 3 ) and with AV 7a alone in three patients, with current AV 14-11 infection giving significant heterotypic anamnestic responses to these types. The HI and SN antibody titers of the patients' sera to prototypes AV 3 (G.B.) and 7a (S-1058) were identical to those obtained with representative strains from this outbreak (274 and 265, respectively). Prototype AV 11 (Slobitski) virus gave HI and SN serum titers which were similar but somewhat lower than those obtained with a representative AV 14-11 isolate (273) ( Table 3) . Antibodies to prototype AV 14 (deWit) were not detected in any patient's sera by HI test but were detected to low levels by the SN test. The clear and consistent discrepancy between antibody titers in the animal antisera (Table 2 ) and those in the human sera (Table 3) is difficult to explain. The test results were always repeatable and were similar for the four rabbits and guinea pigs (as one set of data) and for the 13 patients (as another set of data). The laboratory animals were immunized by subcutaneous injections of virus emulsified in adjuvant; they experienced no natural infection. The patients, however, experienced natural infection not only with AV 14-11 but earlier with antigenically related viruses (AV 3 and 7a) as well. Undoubtedly, the immune response is different for these groups, and this may account for the differing patterns of HI and SN data. In any event, the discrepancies (namely, no HI titer to AV 14 in human sera but high titers in animal sera; low but definite SN titers to AV 14 in human sera but no titers in animal sera; and VOL. 13, 1976 on November 2, 2017 by guest http://iai.asm.org/ Downloaded from 
